DILTIAZEM HCl S.R. CAPSULES

200 mg - 300 mg
  • Treatment of hypertension, angina pectoris and some types of arrhythmia.
    (Diltiazem is a nondihydropyridines (non-DHP) calcium channel blocker used in the therapy and prophylaxis of coronary insufficiency, exertional angina, angina at rest, Prinzmetal vasospastic angina and post-infarct status, essential hypertension of mild and moderate grade.)
  • Posology: once daily
  • Dossier available, including bioequivalence studies vs Mono-Tildiem LP (Sanofi Aventis, France)
  • CPP available
  • Registration underway: Tunisia​
  • Marketing authorization granted: Belgium, France, Germany, Italy, Luxemburg, Spain, The Netherlands
LEGENDA :
Diltiazem HCl S.R. capsules (200 mg - 300 mg) means Diltiazem HCl Slow Release or Sustained Release capsules (200 mg - 300 mg) and corresponds to Diltiazem HCl P.R., i.e. Prolonged Release, capsules, as well as to Diltiazem HCl E.R. or X.R., i.e. Extended Release, capsules, and to Diltiazem HCl M.R., i.e. Modified Release, capsules (200 mg - 300 mg) .
Do you need more information?
Company:
* Name and Surname:
Address:
City:
District:
Cap:
Country:
* E-mail:
Phone:
Fax:
Write for special requests:
Mandatory Fields *
Valpharma S.p.A. - Via Ranco, 112 - 47899 - Serravalle - Tel. +378 0549 900936 - E-mail: valpharma@valpharma.com- Privacy Policy - C.o.E. SM02686
Credits TITANKA! Spa 2015